These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 8699534

  • 1. Immunohistochemical evidence of neuroprotection by R(-)-deprenyl and N-(2-hexyl)-N-methylpropargylamine on DSP-4-induced degeneration of rat brain noradrenergic axons and terminals.
    Zhang X, Zuo DM, Davis BA, Boulton AA, Yu PH.
    J Neurosci Res; 1996 Feb 15; 43(4):482-9. PubMed ID: 8699534
    [Abstract] [Full Text] [Related]

  • 2. Neuroprotection by R(-)-deprenyl and N-2-hexyl-N-methylpropargylamine on DSP-4, a neurotoxin, induced degeneration of noradrenergic neurons in the rat locus coeruleus.
    Zhang X, Zuo DM, Yu PH.
    Neurosci Lett; 1995 Feb 15; 186(1):45-8. PubMed ID: 7540268
    [Abstract] [Full Text] [Related]

  • 3. Neuroprotective effects of some monoamine oxidase-B inhibitors against DSP-4-induced noradrenaline depletion in the mouse hippocampus.
    Yu PH, Davis BA, Fang J, Boulton AA.
    J Neurochem; 1994 Nov 15; 63(5):1820-8. PubMed ID: 7931338
    [Abstract] [Full Text] [Related]

  • 4. Depletion of NOS activity in the rat dentate gyrus neurons by DSP-4 and protection by deprenyl.
    Zhang X, Yu PH.
    Brain Res Bull; 1995 Nov 15; 38(4):307-11. PubMed ID: 8535851
    [Abstract] [Full Text] [Related]

  • 5. Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals.
    Fritschy JM, Grzanna R.
    Neuroscience; 1989 Nov 15; 30(1):181-97. PubMed ID: 2747911
    [Abstract] [Full Text] [Related]

  • 6. Neurochemical and neuroprotective effects of some aliphatic propargylamines: new selective nonamphetamine-like monoamine oxidase B inhibitors.
    Yu PH, Davis BA, Durden DA, Barber A, Terleckyj I, Nicklas WG, Boulton AA.
    J Neurochem; 1994 Feb 15; 62(2):697-704. PubMed ID: 8294932
    [Abstract] [Full Text] [Related]

  • 7. Neurochemical, neuroprotective and neurorescue effects of aliphatic N-methylpropargylamines; new MAO-B inhibitors without amphetamine-like properties.
    Yu PH, Davis BA, Zhang X, Zuo DM, Fang J, Lai CT, Li XM, Paterson IA, Boulton AA.
    Prog Brain Res; 1995 Feb 15; 106():113-21. PubMed ID: 8584647
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of MAO B, but not MAO A, blocks DSP-4 toxicity on central NE neurons.
    Gibson CJ.
    Eur J Pharmacol; 1987 Sep 02; 141(1):135-8. PubMed ID: 3117577
    [Abstract] [Full Text] [Related]

  • 9. Selective effects of DSP-4 on locus coeruleus axons: are there pharmacologically different types of noradrenergic axons in the central nervous system?
    Fritschy JM, Grzanna R.
    Prog Brain Res; 1991 Sep 02; 88():257-68. PubMed ID: 1726027
    [Abstract] [Full Text] [Related]

  • 10. Neurotoxins and monoamine oxidase inhibition: new aspects.
    Finnegan KT.
    Mov Disord; 1993 Sep 02; 8 Suppl 1():S14-9. PubMed ID: 8302303
    [Abstract] [Full Text] [Related]

  • 11. Protection against DSP-4-induced neurotoxicity by deprenyl is not related to its inhibition of MAO B.
    Finnegan KT, Skratt JJ, Irwin I, DeLanney LE, Langston JW.
    Eur J Pharmacol; 1990 Aug 02; 184(1):119-26. PubMed ID: 2120076
    [Abstract] [Full Text] [Related]

  • 12. Determination of the norepinephrine level by high-performance liquid chromatography to assess the protective effect of MAO-B inhibitors against DSP-4 toxicity.
    Haberle D, Magyar K, Szöko E.
    J Chromatogr Sci; 2002 Oct 02; 40(9):495-9. PubMed ID: 12433110
    [Abstract] [Full Text] [Related]

  • 13. The response of noradrenergic axons to systemically administered DSP-4 in the rat: an immunohistochemical study using antibodies to noradrenaline and dopamine-beta-hydroxylase.
    Fritschy JM, Geffard M, Grzanna R.
    J Chem Neuroanat; 1990 Oct 02; 3(4):309-21. PubMed ID: 2204356
    [Abstract] [Full Text] [Related]

  • 14. Acute action of DSP-4 on central norepinephrine axons: biochemical and immunohistochemical evidence for differential effects.
    Grzanna R, Berger U, Fritschy JM, Geffard M.
    J Histochem Cytochem; 1989 Sep 02; 37(9):1435-42. PubMed ID: 2768812
    [Abstract] [Full Text] [Related]

  • 15. (-)-Deprenyl fails to promote axonal regeneration of retinal ganglion cells in vitro and in vivo.
    Rosenstiel P, Sievers J, Lucius R.
    Cell Tissue Res; 2002 May 02; 308(2):167-75. PubMed ID: 12037575
    [Abstract] [Full Text] [Related]

  • 16. R(-)-deprenyl potentiates dopamine-induced cytotoxicity toward catecholaminergic neuroblastoma SH-SY5Y cells.
    Lai CT, Yu PH.
    Toxicol Appl Pharmacol; 1997 Jan 02; 142(1):186-91. PubMed ID: 9007048
    [Abstract] [Full Text] [Related]

  • 17. [Effect of selegiline against selective neurotoxins].
    Magyar K.
    Vopr Med Khim; 1997 Jan 02; 43(6):504-14. PubMed ID: 9503567
    [Abstract] [Full Text] [Related]

  • 18. (-)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties.
    Magyar K, Szende B.
    Neurotoxicology; 2004 Jan 02; 25(1-2):233-42. PubMed ID: 14697898
    [Abstract] [Full Text] [Related]

  • 19. Restoration of ascending noradrenergic projections by residual locus coeruleus neurons: compensatory response to neurotoxin-induced cell death in the adult rat brain.
    Fritschy JM, Grzanna R.
    J Comp Neurol; 1992 Jul 15; 321(3):421-41. PubMed ID: 1506478
    [Abstract] [Full Text] [Related]

  • 20. The pharmacology of B-type selective monoamine oxidase inhibitors; milestones in (-)-deprenyl research.
    Magyar K, Szende B, Lengyel J, Tekes K.
    J Neural Transm Suppl; 1996 Jul 15; 48():29-43. PubMed ID: 8988460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.